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Hemoglobinuria-related acute kidney injury is driven
by intrarenal oxidative reactions triggering a heme
toxicity response
JW Deuel1,9, CA Schaer1,2,9, FS Boretti3, L Opitz4, I Garcia-Rubio5,6, JH Baek7, DR Spahn2, PW Buehler*,7 and DJ Schaer*,1,8
Intravascular hemolysis can result in hemoglobinuria with acute kidney injury. In this study we systematically explored two in vivo
animal models and a related cell culture system to identify hemoglobinuria-triggered damage pathways. In models of stored blood
transfusion and hemoglobin (Hb) exposure in guinea pigs and beagle dogs we found that hemoglobinuria led to intrarenal
conversion of ferrous Hb(Fe2+) to ferric Hb(Fe3+), accumulation of free heme and Hb-cross-linking products, enhanced
4-hydroxynonenal reactivity in renal tissue, and acute tubule injury. These changes were associated in guinea pigs with activation
of a renal cortex gene expression signature indicative of oxidative stress and activation of the unfolded protein response (UPR).
Tubule cells of hemolytic animals demonstrated enhanced protein expression of heme oxygenase and heat shock protein and
enhanced expression of acute kidney injury-related neutrophil gelatinase-associated lipocalin. These adverse changes were
completely prevented by haptoglobin treatment. The in vivo findings were extrapolated to a MS-based proteome analysis of SILAC-
labeled renal epithelial cells that were exposed to free heme within a concentration range estimate of renal tubule heme exposure.
These experiments confirmed that free heme is a likely trigger of tubule barrier deregulation and oxidative cell damage and
reinforced the hypothesis that uncontrolled free heme could trigger the UPR as an important pathway of renal injury during
hemoglobinuria.
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Hemolysis is a common pathophysiologic process. It occurs in
numerous conditions, including genetic hemoglobinopathies
and malaria, the transfusion of stored red blood cells, and
during therapeutic procedures requiring extracorporeal assist.
These conditions may release hemoglobin (Hb), which
contributes to hemolysis-associated adverse clinical out-
comes, such as endothelial dysfunction, oxidative vascular
toxicity, and kidney injury.1
The toxicity of cell-free Hb has been attributed to a number
of its unique properties. First, Hb readily decays into
heterodimers that are considered to be small enough to
extravasate and may enter tissues, such as the kidney, that
have less antioxidant capacity than blood.1 Second, Hb
interacts with ligands other than oxygen, namely nitric oxide
(NO) and peroxides.2,3 These reactions are related to NO
depletion and vascular dysfunction and may trigger oxidative
tissue damage during free Hb exposure. Third, ferric Hb(Fe3+),
which is a product of Hb autoxidation or Hb reactions with
endogenous oxidants, can release free heme. Free heme
is a potent trigger of lipid peroxidation and a promoter of
inflammation.4–6 At high concentrations, heme can act as an
endogenous inhibitor of the proteasome and as a trigger of the
response to unfolded proteins in vitro.7
Under physiologic conditions, Hb toxicity remains controlled
by a specialized scavenger system. Free Hb is bound by the
plasma protein haptoglobin, and the large molecular size Hb:
Hp complexes are ultimately cleared by spleen and liver
macrophages expressing the Hb scavenger receptor CD163.8
However, during more severe hemolysis these protective
systems are saturated and glomerular filtration of free Hb
becomes the major pathway that removes Hb from the
circulation. In a recent pharmacokinetic analysis of free Hb
clearance in dogs, we determined that free Hb in plasma is
cleared from the circulation with a half-life ofo1 h.9 Although
1Division of Internal Medicine, University of Zürich, Zürich, Switzerland; 2Institute of Anesthesiology, University of Zürich, Zürich, Switzerland; 3Clinic for Small Animal
Internal Medicine, University of Zürich, Zürich, Switzerland; 4Functional Genomics Center Zürich, Swiss Federal Institute of Technology Zürich/University of Zürich, Zürich,
Switzerland; 5Laboratory of Physical Chemistry, ETH Zürich, Zürich, Switzerland; 6Centro Universitario de la Defensa, Carretera de Huesca, Zaragoza, Spain; 7Laboratory
of Biochemistry and Vascular Biology, Center of Biologics Evaluation and Research (CBER), FDA, Silver Spring, MA, USA and 8Institute of Evolutionary Medicine,
University of Zürich, Zürich, Switzerland
*Corresponding author: PW Buehler, Laboratory of Biochemistry and Vascular Biology, Center of Biologics Evaluation and Research (CBER), FDA, 10903 New Hampshire
Ave, Silver Spring, MD 20993, USA, Tel: +1 240 402 9411;
or DJ Schaer, Division of Internal Medicine, University Hospital CH-8091, Zürich, Switzerland, Tel: +41 44 255 2382; Fax: +41 44 255 45 67.
E-mail: paul.buehler@fda.hhs.gov or dominik.schaer@usz.ch
9These authors contributed equally to this work.
Received 04.9.15; revised 25.11.15; accepted 30.11.15; Edited by A Finazzi-Agro'
Abbreviations: 4-HNE, 4-hydroxynonenal; AKI, acute kidney injury; ATP, adenosine triphosphate; AUC, area under the curve; EPR, electron paramagnetic resonance;
ER, endoplasmatic reticulum; FCS, fetal calf serum; FDR, false discovery rate; FTH1, ferritin heavy chain 1; FTL, ferritin light chain; GSH, reduced gluthatione; Hb,
hemoglobin; Hb(Fe2+), ferrous hemoglobin; Hb(Fe3+), ferric hemoglobin =met-hemoglobin; HMOX1, heme oxygenase 1; HSP70, heat shock protein 70; LC-MSMS, liquid
chromatography coupled to mass spectrometry x 2; NGAL, neutrophil gelatinase associated lipocalin; NO, nitric oxide; PCR, polymerase chain reaction; SAGE, serial
analysis of gene expression; SILAC, stable isotope labeling with amino acids in cell culture; UPR, unfolded protein response; XBP1, x-box binding protein 1
Citation: Cell Death and Disease (2016) 7, e2064; doi:10.1038/cddis.2015.392
& 2016 Macmillan Publishers Limited All rights reserved 2041-4889/16
www.nature.com/cddis
the renal clearance of Hb is a fast and very effective way
to limit the Hb exposure of other critical tissues such as the
vasculature, the kidney itself can be exposed to large
quantities of free Hb. Therefore, acute kidney injury (AKI)
remains an important complication of acute and severe
intravascular hemolysis. A paradigmatic example is Hb-
triggered AKI as a complication of severe malaria with
hemoglobinuria. This condition was called black water fever
owing to its impressive clinical presentation with dark-colored
urine.10 Renal damage has also been reported to occur
throughout many other acute hemolytic conditions associated
with hemoglobinuria.11–18 The mechanisms of renal damage
during these conditions are considered to be multifactorial and
may involve direct damage to renal tubule cells by glomerular-
filtered Hb.18 However, no systematic studies have so far been
reported to explore themolecular mechanisms of Hb-triggered
renal damage during hemolysis.
In the current study, we searched for hemoglobinuria-
associated changes of the renal cortical tissue transcriptome.
In addition, we investigated disease-related biochemical and
molecular pathways that may be activated in heme-exposed
renal epithelial cells. Cumulatively, our findings show that renal
Hb exposure led to the accumulation of large quantities of
oxidized ferric Hb(Fe3+) in tissues, heme release, and
secondary radical reactions. These conditions may promote
a heme-related cellular damage pathway in tubule epithelial
cells that is characterized by an oxidative stress response and
an activated response to unfolded proteins, which may
ultimately lead to renal tubule toxicity and AKI.
Results
The renal transcriptional response to hemoglobinuria in
guinea pigs indicates that tubular damage is caused by
oxidative stress and an activated response to unfolded
proteins. Isovolemic transfusion of guinea pigs with
10-unit equivalents of old blood, which consisted of red
blood cells that were stored for 28 days, led to moderate
hemoglobinuria.14 Old blood transfusion resulted in systemic
free Hb total exposure (AUC0–∞) of 4600 μmol heme-h/l,
which was primarily cleared by the kidney within 24 h.
No measurable hemolysis occurred after the transfusion of
10-unit equivalents of new blood.
The transfusion-associated hemolysis resulted in brown
discoloration of the kidney, swelling of tubule epithelial cells,
and formation of eosinophil casts in the tubular lumen (Figure 1).
These changes were associated with an increase in the
mRNA expression of neutrophil gelatinase-associated lipocalin
(NGAL), indicating AKI with tubular cell damage.19 No changes
in the morphology or NGAL expression were observed after the
transfusion of fresh blood. Hp treatment at the time of the
transfusion of the old blood prevented the glomerular filtration of
Hb as well as changes in morphology or NGAL expression after
the transfusion.
We obtained renal gene expression profiles from these
kidneys using serial analysis of gene expression (SAGE). We
analyzed renal cortical tissues that were collected from control
(n= 4), new blood-transfused (n= 6), old blood-transfused
(n= 5), and Hp-treated, old blood-transfused (n= 4) animals.
At a false discovery rate (FDR) of 5%, we found 156 transcripts
that were differentially regulated in the old blood-transfused
(hemoglobinuria) animals compared with the new blood-
transfused (no hemoglobinuria) animals (Figure 2a, and
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Figure 1 Renal outcome of blood transfusion-related hemolysis in guinea pigs.
(a) Macroscopic view of kidneys of new blood-transfused and old blood-transfused
guinea pigs at 24 h after treatment. (b) Hematoxylin and eosin-stained kidney
sections of new blood-transfused, old blood-transfused, and old blood-transfused,
haptoglobin (Hp)-treated animals at 24 h after treatment. (c) Renal tissue expression
of lipocalin 2 (LCN2)/neutrophil gelatinase-associated lipocalin (NGAL) mRNA at
24 h after treatment (*Po0.01)
Figure 2 Hemolysis triggered renal gene expression. (a) Volcano plot of all gene expression tags that were found by serial analysis of gene expression (SAGE) of guinea pig
renal tissues. LogFC indicates the relative gene expression in renal cortical tissues of old blood-transfused versus new blood-transfused animals. The threshold of significance
was set at a false discovery ratio (FDR)o0.05. Selected transcripts are labeled and color-coded for related functions: red—protein folding/response to unfolded proteins; green—
response to oxidative stress; blue—inflammation. The significant results of a MetaCore analysis for the enrichment of functional networks among significantly upregulated genes
are shown at the bottom. The light-gray area in the volcano plot highlights the top 40 upregulated genes that were re-analyzed in the hierarchical clustering analysis shown in (b).
The color-coded gene expression indicates the ratio of normalized SAGE-tagged counts of treated versus untreated control tissues (upregulated genes are red). (c) Box plots of
SAGE mRNA transcript counts for selected genes (*Po0.05). (c) Sample box plots of normalized sequence counts. *po0.05. (d) Immunofluorescence analysis of heat shock
protein 70 (Hsp70) and heme oxygenase-1 (HMOX1) in renal tissues of control and old blood-transfused animals. Control slices were stained with goat anti-rabbit (Alexa 568)
secondary antibody without any primary antibody. Images were acquired with a Zeiss Axioskop 2 epifluorescence microscope at an original magnification of × 200
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Supplementary data). In total, 149 transcripts were signifi-
cantly upregulated in the old blood-transfused animals. Along
with the suppression of the endogenous heme synthesis
pathway (i.e., 5′-aminolevulinate synthase 1), the induction of
heme oxygenase-1 (HMOX1) suggests that this response is
driven by the exposure to free heme.
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A MetaCore analysis of the upregulated genes for signifi-
cantly enriched functional networks is also shown in Figure 2a.
The highest scores are associated with the response to
unfolded proteins and the endoplasmic reticulum (ER) stress
pathway of apoptosis, as well as the response to oxidative
stress. Signature genes representing these processes, aswell
as inflammation-related transcripts, are color-coded in the
volcano plot. Figure 2b shows a hierarchical clustering
analysis of the 40 most upregulated genes across all
treatment conditions (including new blood transfusion and
old blood+Hp transfusion data). The clustering analysis clearly
suggests that the Hp-mediated prevention of hemoglobinuria
normalizes the renal gene expression pattern toward the renal
gene expression profile of new blood-transfused animals. The
Hp rescue supports the hypothesis that renal gene expression
changes in this model represent a specific renal response
to Hb/heme toxicity. Figure 2c shows sample box plots of
normalized sequence counts for heat shock factor 2, heat
shock protein 70 (HSP70 member GRP78), glutamate–
cysteine ligase modifier subunit, and HMOX1.
Immunofluorescence confirmed that renal Hb exposure
triggered overexpression of HMOX1 and the unfolded protein
response (UPR) chaperone HSP70 in tubule epithelial cells
(Figure 2d).
Hemoglobinuria-associated intrarenal oxidative proces-
ses and free heme release. To substantiate the hypothesis
that oxidative processes occur in the kidney during acute
hemoglobinuria, we examined the renal tubule Hb/iron
exposure, ferric Hb(Fe3+) accumulation, and markers of oxi-
dative protein modification in the kidneys of old blood-trans-
fused guinea pigs and in the urine of hemoglobinuric dogs.
Electron paramagnetic resonance (EPR) spectra of renal
tissues from old blood-transfused animals were recorded at 6K
and showed a strong signal around g=6, which is indicative of
high-spin ferric Hb(Fe3+) (Figure 3a). No high-spin ferric
Hb was present in the control tissues or renal tissues of old
blood-transfused, Hp-treated guinea pigs. High-spin ferric Hb
concentrations in renal tissues of old blood-transfused animals
were 425±370 μM (n=3). In this model of transfusion-related
hemolysis,495% of circulating, plasma-free Hb remained in the
ferrous (Fe2+) state throughout the experiment, which indicates
that the ferrous to ferric transformation must occur within the
kidney tissue parenchyma and urinary filtrate. Figure 3b shows
iron- and Hb-stained (Okajima staining) renal tissue sections. In
old blood-transfused animals, strong Hb and iron deposition was
observed in the tubule lumen and epithelial cells, respectively. Hp
treatment prevented renal Hb exposure. The inset in Figure 3b
shows that Hb predominantly accumulates in the tubule lumen
and in proximal tubule epithelial cells.
Figure 3c shows the staining of renal tissues for
4-hydroxynonenal (4-HNE), which is a lipid peroxidation
marker for oxidative damage to tissue proteins. Renal tissues
from old blood-transfused animals exhibited 4-HNE-positive
staining. In control, new blood-transfused, and old blood-
transfused, Hp-treated animals, 4-HNE was not detected.
As an alternative model of hemoglobinuria with a higher
yield of urine volume we continuously infused adult beagle
dogs with stroma-free ferrous Hb(Fe2+) for 6 h. Total Hb
exposure resulted in a plasma AUC0-∞ of 4532± 251 μmol
heme-h/l and a urinary Hb accumulation of 312.5± 35 μmol/l.
To search for markers of intrarenal oxidative processes in this
model, we analyzed the urine for Hb-cross-linking products,
which represent the end product of oxidative Hb reactions.20
Figure 4a shows a reducing Hb-specific western blot from four
representative dog urine samples in parallel with a hydrogen
peroxide-treated Hb sample (hydrogen peroxide:Hb=10 : 1,
1 h reaction time at 37 °C). Covalent globin cross-linking
products (dimer, trimer, tetramer, etc.) were detected in all dog
urine samples during, but not before hemoglobinuria occurred.
We also quantified free heme in dog urine by using a
hemopexin capture assay. Urine-free-heme concentrations
were within the range of 40–600 μM during hemoglobinuria.
To estimate the range of free heme in tubule system these
urine heme concentrations were normalized to a creatinine
concentration of 90 μM, which is the concentration that is
expected in the primary glomerular filtrate. The normalized
data shown in Figure 4b indicate that free heme accumulation
in the renal tubule systemmay be within a range of 2–15 μM in
proximal segments to up to several hundred μM in more distal
tubule compartments.
Free heme toxicity in human proximal tubule (HK-2)
cells. Free heme, which is released from ferric Hb(Fe3+),
was identified as a likely mediator of hemoglobinuria-
associated damage. To estimate the potential toxicity of free
heme in urine toward tubule cells and to validate the in vivo
gene expression studies with an in vitro model, we treated
HK-2 renal tubule epithelial cells with free heme under serum-
free conditions. As shown in Figure 5a, heme concentrations
of 10 μM trigger an acute but transient decrease in epithelial
electrical resistance, whereas concentrations420 μM cause
an irreversible loss of barrier function. Accordingly, heme
exposures of more than 10 μM caused the significant and
progressive depletion of cellular ATP, which was measured
after an 8-h exposure period. This ATP depletion was
prevented by the addition of the heme scavenger, hemopexin
(Figure 5b). Reduced glutathione (GSH) was also depleted
after 4 h of heme exposure, indicating that heme induces
oxidative stress in exposed cells (Figure 5c). These data
suggest that the estimated free heme concentrations that
occur in the renal tubular system during severe intravascular
hemolysis are in the range of heme concentrations that could
trigger oxidative stress and cell damage to the renal
epithelium.
Quantitative proteome profiling identifies the response to
unfolded proteins as a potential damage pathway in
heme-exposed HK-2 cells. We incubated SILAC-labeled
HK-2 cells with or without heme (10 and 40 μM) for 8 h and
defined heme-triggered proteome changes by LC-MS/MS. In
six replicate experiments, we identified and relatively
quantified 3108 proteins. The volcano plots in Figure 5d
illustrate the relative protein expression changes of all
proteins that were identified in at least three of the six
analyzed biologic replicates. In agreement with the electrical
cell–substrate impedance sensing data described above, the
proteome changes triggered by 10 μM heme were indicative
of an adaptive response with prominent induction of HMOX1
and ferritin light (FTL) and heavy (FTH1) chains (Figure 5d,
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left panel). However, in the presence of 40 μM heme, the toxic
response was characterized by the strong induction of heat
shock proteins, namely HSP70 (HSPA1B, HSPA4, HSPA5,
DNAJB1), HSP72 (HSPA1A), HSP105 (HSPH1), and HSP10
(HSPE1), as well as the proteasome adaptor protein
sequestosome. These proteins were upregulated in addition
to the adaptive HMOX1 and ferritin (FTL, FTH1) (Figure 5d,
right panel). Figure 5e shows box plots of the relative
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Figure 3 Renal hemoglobin accumulation and oxidative changes. (a) Electron paramagnetic resonance (EPR) spectroscopy of guinea pig kidney lysates from new blood-
transfused, old blood-transfused, and old blood-transfused, Hp-treated animals. The spectra represent summed spectra of three samples from three individual animals measured
at a 1 : 2 dilution of kidney lysates. The red spectrum indicates a ferric Hb(Fe3+) standard (200 μM). The middle panel shows the whole recorded EPR spectrum. The right and left
panels are zoomed regions around g= 6 (ferric Hb signal) and g= 2 (free radical signal). (b) Histochemistry for iron (left panels) and Okajima staining for Hb (right panels) of
guinea pig renal tissues at 24 h after treatment. (c) Immunohistochemistry for 4-hydroxynonenal (4-HNE) at 24 h after treatment. The inset shows a higher resolution
magnification of a glomerulus
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expression levels of selected signature proteins. Details of
protein expression data are provided in the Supplementary
data.
Figure 6a shows a hierarchical clustering analysis of all
proteins that exhibit significantly different expression patterns
between heme-treated and control cells (FDR 0.05, fold
change41.5). With this analysis, we could differentiate three
principle clusters of proteins that were altered in expression
by heme treatment. A small number of proteins (brown
cluster) were induced by both heme concentrations.MetaCore
analysis related these genes to iron transport. A second
cluster of proteins (green cluster) identified genes with
increased expression at 40 μM. These ‘heme stress’-related
proteins represent the response to unfolded proteins, as a
potential pathway of cell damage. The third cluster identified a
heme-suppressed group of proteins (blue cluster). This group
represents biologic functions that are related to cell adhesion
and proteolysis. In the presence of both 10 and 40 μM, the
transferrin receptor was identified as the most suppressed
protein.
The heme-triggered activation of the UPR, which was
suggested by the screening analysis, could be confirmed in
HK-2 cells by the reverse transcription-polymerase chain reaction
(PCR)-based splice assay for X-box binding protein 1 (XBP1).21
The ratio of spliced XBP1 to either total XBP1 or unspliced XBP1
was strongly increased by 40 μM heme for 4 and 8 h. A minor
increase in spliced XBP1 was observed with exposure to a
sub-toxic concentration of heme (o10 μM) (Figure 6b).
Discussion
In this study, we systematically evaluated an animal model of
hemoglobinuria in the guinea pig, dog, and a relevant in vitro
cell culture model to characterize molecular pathways and
underlying biochemical mechanisms that may lead to renal
injury during hemolysis. The key observations were related
to the sequence of intrarenal oxidative reactions and free
heme-triggered toxicity, which may ultimately lead to tubular
dysfunction and damage.
Ferrous Hb(Fe2+) is the principle iron transition state of free
Hb that is found in the circulation of patients with hemolysis. It
exhibits NO-scavenging activity, which can cause hyperten-
sion and ischemia. However, ferrous Hb is relatively inert
regarding its potential toxic effect on cells and tissues.
Therefore, it is possible that renal damage during hemoglo-
binuria may be caused by secondary reaction products of
glomerular-filtered ferrous Hb(Fe2+). A candidate mediator of
secondary Hb toxicity is free heme, which can be released
when ferrous Hb(Fe2+) is oxidized to ferric Hb(Fe3+). Toxicity of
free heme has been mainly attributed to its pro-oxidative
nature, whichmay either directly damage cells or may promote
generation of toxic lipid-oxidation products.22–27 Several
pathways of renal tubule cell death may be relevant to AKI
and renal failure following sustained exposures to Hb and its
components (globin, heme, and iron). Besides apoptosis, the
two non-apoptotic cell death pathways necroptosis28 and
ferroptosis29,30 are of particular interest in response to heme-
triggered oxidative stress. Iron-regulated ferroptosis has been
shown to be an important cell death pathway in the kidney and
upon cardiac ischemia and reperfusion injury.29,30 In the
kidney, ischemia followed by reperfusion has also been shown
to induce ferroptosis in renal tubules though lipid peroxide
accumulation. This process could be prevented by potent
inhibitors of lipid peroxidation known as ferrostatins.31 We
have examined the potential effects of specific pharmacologic
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inhibitors of apoptosis, necroptosis, and ferroptosis in our
HK-2 cell culture heme toxicity model but could not show any
significant effects, indicating that none of these pathways is
exclusively active in heme-triggered cell death (data not
shown).
We have recently shown that two principle and mutually
interacting activities of heme can cause cellular damage if
the intracellular levels of porphyrin can not be adequately
controlled by heme oxygenases.7 At high intracellular con-
centrations, heme and other porphyrins can bind to high-
affinity-binding sites within the 26S catalytic unit of the
proteasome and inhibit its function.7,32 This proteasome
inhibitor function of heme is thought to impair cellular repair
mechanisms, thus accelerating heme-induced oxidative injury.
Ultimately, we found that uncontrolled cellular heme levels can
activate the response to unfolded proteins and associated
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and heme-treated (4 h) HK-2 cells (n= 8 replicates per treatment). (d) Stable isotope labeling by amino acids in cell culture (SILAC)-based mass spectrometry analysis of the
heme-induced proteome. The two volcano plots illustrate differential protein expression of HK-2 cells that were treated with 10 μM heme (left plot) or 40 μM heme (right plot) for
12 h. The x axis indicates relative log2 protein expression ratios of treated versus control cells. The data are representative of six biologic samples per condition. Significantly
regulated proteins (in any condition) are highlighted in blue (FDR 5%). Only proteins that were detected in at least three of six samples per condition were included in this analysis.
(e) Box plot representation of selected signature protein regulation (n= 6 biologic replicas per condition)
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apoptosis pathways in mouse embryonic fibroblast cells. The
UPR is a conserved response, which can be triggered by
several extracellular insults, such as low nutrients, hypoxia,
and inhibition of proteasome function. Such triggers can result
in the accumulation of misfolded proteins in the ER, thereby
causing ER stress and initiating the UPR.33,34 The UPR
increases the biosynthetic capacity and decreases the
biosynthetic burden of the ER to maintain cellular homeo-
stasis. However, when the stress cannot be compensated by
the UPR, cellular apoptosis occurs.
The idea that severe hemolysis in vivo could trigger
oxidative stress and the UPR in kidneys was reinforced
in our studies by the analysis of the renal transcriptome of
old blood-transfused guinea pigs. In a MetaCore analysis
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Figure 6 Free heme-triggered gene expression in renal epithelial HK-2 cells. (a) Hierarchical clustering analysis of all HK-2 proteins that were up (red) or down (blue)
regulated by 10 or 40 μM heme compared with control cells. Only proteins that were detected in all six samples per condition were included in this analysis. Three protein clusters
were identified. The brown cluster was upregulated by both heme exposures, the green cluster was only upregulated at 40 μM heme, and the blue cluster was downregulated by
40 μM heme. In addition, the analysis identified the upregulation of HMOX1 and the suppression of the transferrin receptor (TFR) in all heme-treated samples. Significant results
of a MetaCore analysis for the enrichment of functional process networks in the three different protein clusters are shown on the left. (b) X-box binding protein 1 (XBP1) splicing in
heme-exposed (8 h) HK-2 cells was measured as a marker for the unfolded protein response
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of the hemoglobinuria-associated transcriptome, we identified
the same cellular processes that were also characteristic of
the combined oxidative stress and proteasome inhibitor
response of heme-exposed murine embryonic fibroblasts in
our previous studies, as well as in the proteomic profile of
heme-exposed HK-2 cells in the current study. In particular,
the response to unfolded proteins appeared to be the most
enriched process in all heme exposure models. The renal
gene regulation data could be validated by the immunohisto-
logic examination of HSP70 and HMOX1, which were both
enhanced in the proximal tubule cells of old blood-transfused
animals. The described changes were associated with an
increase in the mRNA expression of renal NGAL, which is a
relevant marker of renal tubular injury in AKI. The old blood
transfusion-associated gene expression was not activated in
animals that were either transfused with new blood or treated
with the Hb scavenger, haptoglobin. This indicates that
hemoglobinuria is the essential trigger of the observed tissue
responses.
Other studies demonstrated that heme can trigger the
activation of Toll-like receptor 4 and inflammasomes, thus
leading to inflammatory reactions.5,35–37 In our SAGE analysis
of kidneys from old blood-transfused guinea pigs, a number of
inflammation-associated gene productswere upregulated and
this was associated with sporadic macrophage accumulation
in kidney (data not shown). None of these gene products
was detected in new blood-transfused or old blood-transfused,
Hp-treated animals. This pro-inflammatory response may
represent either an unspecific tissue response to injury or it
points to a specific activation of pro-inflammatory signaling
by heme.
To substantiate the concept that oxidative Hb reactions with
accumulation of ferric Hb(Fe3+) and free heme may lead to
tubule damage during hemoglobinuria we have searched for
markers of Hb-triggered oxidative processes in two in vivo
models of hemoglobinuria. First, quantification of high-spin
ferric Hb(Fe3+), which is the initial Hb oxidation product
resulting from the oxidation of ferrous oxyHb(Fe2+), in the
kidneys of the old blood-transfused guinea pigs suggests
very high concentrations of ferric Hb can accumulate in renal
tissues at 24 h after old blood transfusion. These EPR
spectroscopy data refer to the total renal ferric Hb(Fe3+)
concentration. However, the distribution of iron and Hb
deposition was not homogeneous within the kidney, and the
highest accumulation was detected in proximal tubule cells.
This heterogeneity of renal Hb distribution may suggest
exposures to considerably higher ferric Hb(Fe3+) concentra-
tions (4800 μM). Within ferric Hb(Fe3+), heme coordinates
weakly, and ferric Hb(Fe3+) is therefore a more readily
available source of heme. We also used a hemopexin
capture assay in the urine of hemoglobinuric dogs and
estimated that 410 μM of heme are in a very loosely protein
bound state and could be considered as free heme in renal
tubular fluid. With the4400 μM ferric Hb(Fe3+) concentration
estimate that could be measured by EPR in the guinea pig
renal cortex, we expect that significantly higher concentrations
of free heme would occur locally during more severe renal Hb
exposure.
In the absence of high-affinity scavenger proteins, such as
hemopexin, free heme can transfer from ferric Hb(Fe3+) to
lipid compartments, where it may accelerate peroxidative
reactions. These reactions lead to the formation of lipid
peroxides and toxic lipid-oxidation end products.6 The
accumulation of 4-HNE adducts in the renal tissue
of old blood-transfused guinea pigs suggests that such
reactions do occur in the kidney during severe hemolysis. It
has also been proposed that the peroxidase reaction of ferric
Hb(Fe3+) with hydrogen peroxide or lipid peroxides could
accelerate Hb toxicity through the generation of free radicals
and the accumulation of globin oxidation products.20,38–40
In this study, covalent globin cross-linking products
were identified in the urine of our canine hemoglobinuria
model. Such cross-linking products typically occur as
a result of radical-generating Hb reactions, presumably as a
result of dityrosine formation between radicalized α/β globin
chains.
The above-discussed findings provide strong in vivo evidence
that high concentrations of ferric Hb(Fe3+) and free heme can
accumulate in the renal cortex during hemolysis. Subsequently,
heme-triggered oxidative reactionsmay lead to tubular damage.
We extrapolated these observations to an in vitro toxicity model
to reinforce potential cellular damage pathways in a renal
epithelial cell line. These studies suggest that the estimated
in vivo free heme concentrations in tubules may trigger a range
of cellular responses from adaptive to toxic. At the lower heme
concentration tested (10 μM), the response of human kidney
HK-2 cells appeared to be adaptive with the strong induction of
heme defense genes (HMOX1 and ferritin). This lower heme
exposure resulted in a transient deregulation of epithelial barrier
function, which recovered completely within a few hours.
However, at higher heme concentrations (20 and 40 μM), we
observed a cytotoxic response with the irreversible breakdown
of the epithelial barrier. Similar to our previous studies in
HMOX1 knockout cells, we found that the toxic heme exposure
ofHK-2 renal epithelial cells causedoxidative cell stresswith the
depletion of cellular GSH and ATP and ultimately triggered the
response to unfolded proteins.
In conclusion, our results suggest that during severe
hemoglobinuria, oxidative processes do occur locally in the
kidney. This promoted the accumulation of ferric Hb(Fe3+) and
the release of free heme in the tubular system. Free heme
triggered an oxidative stress response and the response to
unfolded proteins in epithelial cells, which may ultimately lead
to tubular dysfunction with AKI. The prevention of renal Hb
filtration by Hp may be a therapeutic strategy to block renal Hb
exposure and to rescue renal function in patients with severe
hemoglobinuria.
Materials and Methods
Animal experiments. The US FDA/CBER Institutional Animal Care and Use
Committee approved all animal studies. Surgical procedures, as well as the
collection, storage, and transfusion of red blood cells, were performed, as described
previously.14 Blood was transfused by an 80% volume-by-volume exchange system
at a rate of 0.25 ml/min with new blood (stored for 2 days) or old blood (stored for
28 days). Some animals were treated with 750 mg Hp at the time of old blood
transfusion. Untreated control animals underwent all surgical procedures without
transfusion. Mixed-phenotype Hp from human plasma was obtained from CSL
Behring (Bern, Switzerland). Anesthetized dogs were infused with stoma-free
human ferrous Hb(Fe2+) to a target plasma concentrations of 150 μM free heme for
6 h. Urine was collected by suprabubic puncture.
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SAGE. Total RNA was purified from tissue homogenates with the RNeasy Mini Kit
(Qiagen, Hombrechtikon, Switzerland). An on-column DNA digestion step
(RNase-Free DNase Set, Qiagen) was included. RNA integrity was checked with
a Bioanalyzer 2100 instrument (Agilent Technologies, Basel, Switzerland), and only
high-quality RNA (RNA integrity number47.0) was used for further analyses. Total
RNA (10 μg) was used for library preparation with the SOLiD-SAGE Kit with
Barcoding Adaptor Module (Applied Biosystems, Foster City, CA, USA). Library
sequencing was performed with an AB SOLiD 5500xl system (Applied Biosystems)
at the Functional Genomics Center Zürich in Switzerland.
SOLiD-SAGE tags were analyzed with the SOLiD-SAGE software (v.1.10; Applied
Biosystems) by mapping the SAGE tags to the cavPor3 sequence database. The
output was the copy number of each tag in a particular library. The mean normalized
library size was 11.20 million, 11.86 million, 10.61 million, and 10.17 million reads for
the new blood, old blood, old blood+Hp, and control guinea pig kidney cortex,
respectively. For analysis, the tag length was set to 22 bases, and the maximum
allowed mismatches was set to one. For data normalization and statistical tests to
identify tags that originated from differentially expressed transcripts, we used the
edgeR package (v.2.6.12; www.bioconductor.com). A transcript was considered to be
differentially expressed if all of the following criteria were met: Log2 ratio41, FDR
levelo0.05, and definite presence of the transcript (read count450 in the samples
of at least one group). Centroid clustering analyses of log-transformed ratio data and
visualization were performed with JMP Genomics 5.0 (SAS, Böblingen, Germany).
The treatment discriminative gene cluster consisting of 149 upregulated genes after
old blood transfusion was analyzed with the MetaCore analysis software (Thomson
Reuters, New York, NY, USA) for the enrichment of functional gene networks.
EPR spectroscopy. For EPR analysis snap-frozen renal tissues were partially
homogenized with a tissue homogenizer in cold phosphate-buffered saline (PBS)
(v/v 1 : 1). The experiments were performed in a Bruker Elexsys spectrometer
equipped with a resonator ER 4122 SHQ also from Bruker BioSpin (Fällanden,
Switzerland). The temperature of the samples was 6 K, which was reached using a
He gas-flow cryostat and a temperature controller ITC 503 from Oxford Instruments
(Abingdon, UK). The microwave frequency was 9.46 GHz, the microwave power in
the samples 0.13 mW and the magnetic field was modulated at 100 kHz with an
amplitude of 1 mT. In addition to the renal tissue samples, two standard solutions of
Hb of 100 and 200 μM were measured and used to calculate the concentration of
Hb in the samples. As the signals of Hb in tissue and solution were practically
identical the concentration calculation was based on the intensity ratio of the
spectra.
Western blot analysis of the oxidative polymers of Hb. Dog urine
containing 5 μg Hb, as measured by spectrophotometry, was diluted 1 : 2 in
Läemmli-Buffer containing 5% of 2-mercaptoethanol and boiled at 95 °C for 5 min.
Proteins were separated on a Criterion Any-kD SDS-PAGE Gel (Bio-Rad, Cressier,
Switzerland) and blotted on a polyvinylidene fluoride membrane with 0.4-μm pores
(Thermo Scientific, Reinach, Switzerland). After blocking in 10% goat serum, 10 g/l
bovine albumin, and 0.1% Tween-20, membranes were incubated with a monoclonal
mouse anti-Hb antibody (Abcam, #ab33844, Cambridge, UK) that was diluted
1 : 10 000 in 10% blocking buffer in PBS for 1 h, followed by incubation with a
horseradish peroxidase-coupled goat anti-mouse IgG antibody (Amersham, GE
Healthcare, Glattbrugg, Switzerland) at a dilution of 1 : 10 000 in 10% blocking
buffer in PBS for 6 h. Hb was visualized by using the SuperSignal West
Femto Maximum Sensitivity Substrate (Thermo Scientific) in a Chemidoc-XRS
imager (Bio-Rad). For control samples, pure human HbA1 (10 μM) was mixed
with hydrogen peroxide in a 1 : 10 molar ratio at 37 °C for 60 min in PBS
pH 7.4. Oxidized Hb (5 μg) was then separated on a Criterion Any-kD
Gel and developed using Coomassie Brilliant Blue staining. For alignment of the
blot and SDS-PAGE gel, Precision Plus All Blue Protein Size Markers (Bio-Rad)
were used.
Non-heme iron and globin histochemistry. Kidney sections were
incubated with Perls iron reagent containing 5% potassium ferrocyanide and 2%
hydrochloric acid for 45 min at room temperature, after which they were rinsed in
deionized water. Sections were then incubated with 0.3% hydrogen peroxide and
0.01 M sodium azide in methanol for 30 min at room temperature. All sections were
rinsed in 0.1 M phosphate buffer, pH 7.4, and incubated with diaminobenzidine
(SigmaFast DAB, Sigma) for 3 min. After the incubation, sections were washed in
deionized water and lightly counterstained with Gill’s II hematoxylin. All images were
acquired using an Olympus IX71 inverted microscope equipped with an Olympus
DP70 digital camera. Globin chain deposition (Okajima staining)—sections were
incubated with 100 ml of 5% Alizarin Red and 50 ml of 10% phosphomolybdic acid for
1 h, washed in deionized water, and lightly counterstained with Gill’s II hematoxylin.
Immunohistochemistry and immunofluorescence. Tissue slides
were de-paraffinized and hydrated in SafeClear and graded ethanol preparations.
Antigen retrieval was performed in sodium citrate, and peroxidase inhibition was carried
out in PBS containing 30% hydrogen peroxide and 0.05% Tween-20. Blocking
was carried out by incubations with 10% horse serum and 0.25% Triton X-100 in
PBS for 1 h at ambient temperature. 4-HNE was detected with a mouse monoclonal
primary antibody (Clone HNEJ-2, Genox, Baltimore, MD, United States) and a
biotinylated secondary antibody (anti-mouse IgG rat-adsorbed (BA2001, Vector Labs,
Burlingame, CA, USA), which were visualized with avidin-biotin complex reagent
(Vectastain, Vector labs) and developed with 250 μl diaminobenzidine and hydrogen
peroxide (Sigma-Aldrich, Buchs, Switzerland) for 3 min. Counterstaining was performed
in hematoxylin for 15 s. Slides were viewed, and images were captured under a light
microscope at × 60 magnification. Optimization was carried out by adjusting the
brightness and contrast of all images equally using Adobe Photoshop (Adobe, Adobe
Systems GmbH, Zürich, Switzerland). For immunofluorescence, the following primary
antibodies were used: mouse monoclonal antibody (3A3) against HSP70 (Abcam,
ab5439) and rabbit polyclonal antibody against HMOX1 (Enzo SPA-895, Lausen,
Switzerland). Alexa 568-conjugated secondary antibodies were used (Invitrogen,
Thermo Scientific, Reinach, Switzerland). Images were acquired with a Zeiss
Axioscope 2 fluorescence microscope (Carl Zeiss AG, Feldbach, Austria) with 200-fold
optical magnification. Equal image acquisition settings were used for all images.
Channels were merged with ImageJ software (version 1.48c). Hb chain deposition
(Okajima staining)—sections were incubated with 100 ml 5% Alizarin Red+50 ml 10%
Phosphomolybdic acid for 1 h, washed in deionized water, and lightly counterstained
with Gill’s II hematoxylin.
Heme/hemopexin capture assay. Because heme, ferric Hb(Fe3+), and
hemichrome species extensively aggregate in urine, the direct quantification of free
heme by spectrophotometry in these samples is difficult. In contrast, hemopexin
specifically captures monomeric free heme. The heme–hemopexin complex yields a
clear and specific visible spectrum that is proportional in intensity to the
concentrations of free heme and heme that is loosely attached to proteins. Using
PBS (pH 7.45), dog urine samples were diluted to a final Hb concentration of
10 μM. Control urine samples containing no Hb were diluted by the same factor as
their corresponding treated urine samples. All samples were pre-warmed to 37 °C.
Hemopexin (CSL Behring) was added to a final concentration of 20 μM, and
absorbance spectra were recorded during the interval of 350–650 nm at 2-nm
intervals (25-ms integration time) every 3 min for 1 h, starting 1 min after the
addition of hemopexin using an Agilent Cary 60 spectrophotometer and a Varian
PCB 1500 cuvette heater. The resulting spectra were quantified for methemoglobin,
oxyhemoglobin, and heme–hemopexin using the non-negative least squares
algorithm and the R statistics package, as described previously.41
ECIS and the measurement of cellular ATP and GSH. ECIS was
performed by growing HK-2 cells to confluence on 10E+ ECIS wells (Applied
BioPhysics, Troy, NY, USA) in 1 : 1 DMEM:Ham’s F-12 (Gibco), which was
supplemented with 10% fetal calf serum (FCS), 0.05% ITS-A (Gibco), 100 μM
cortisol (Sigma-Aldrich), and penicillin-streptomycin (Gibco). ECIS resistance,
impedance, and capacitance were recorded over the full spectrum for all wells. After
equilibration, the medium was replaced with serum-free medium for 1 h, and then
heme was added to the cells. The relative concentrations of ATP and GSH were
measured by specific chemiluminescence assays (Promega).
HK-2 SILAC Experiments. HK-2 cells were grown to confluence in 1 : 1
DMEM:Ham’s F-12 medium that was deficient for lysine and arginine and
supplemented with 10% dialyzed FCS, 0.05% ITS-A (Gibco, Thermo Scientific,
Reinach, Switzerland), and 100 μM cortisol (Sigma-Aldrich). Cells were then
labeled with stable isotope-tagged arginine and lysine and cultivated for 24 h in
serum-free medium before treatments with 0 (control), 10, and 40 μM heme. Control
samples were always labeled with light arginine and lysine, whereas the two heme-
exposed samples were labeled with either medium or heavy amino acids. All
samples were lysed with radioimmunoprecipitation assay buffer containing the
Roche complete protease inhibitor cocktail and normalized for protein concentration
(BCA-Assay, Pierce, Thermo Scientific, Reinach, Switzerland). Equal amounts of
light, medium, and heavy labeled lysates were pooled before further processing.
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Proteins were reduced by 10 mM dithiotreitol, carboamidomethylated by 100 mM
iodoacetamide, and digested using 1 μg trypsin (Roche, Basel, Switzerland) per
sample at room temperature overnight. Afterwards, they were cleaned up using
ZipTips (Millipore, Merck, Schaffhausen, Switzerland) and analyzed using an
Orbitrap Velos Mass Spectrometer (Thermo Scientific). Data were analyzed using
MaxQuant.42 Settings are noted in the Supplementary data. The MaxQuant peptide
output was pooled by proteins (if identified by at least a razor peptide), which were
weighted by the total intensity of the detected ion. For statistical analysis (ANOVA,
hierarchical clustering) and generation of plots we used JMP Genomics 6.0 (SAS
Institute Inc.).
Quantitative real-time PCR. Total RNA was isolated from guinea pig
kidneys, and complementary DNA was synthesized. Real-time PCR reactions were
performed using the Applied Biosystems ViiA 7 Real-Time PCR System and its
TagMan Fast Universal PCR Master Mix (Applied Biosystems), according to the
manufacturer’s protocol. The custom-designed TaqMan probes and primer sets
for guinea pig lipocalin 2 (forward: 5′-GTCCCACCACTGAGCAAGAT-3′, reverse:
5′-GTCATCTTTCAGCCCGTAGG-3′, TaqMan probe: 5′-CAAGACAAGTTCCAGG
GGAA-3′) and glyceraldehyde 3-phosphate dehydrogenase (GAPDH;
Cp03755743_g1) were purchased from Applied Biosystems. Real-time PCR for
each gene was performed in triplicate and normalized to GAPDH values. Results
are presented as fold change and expressed as means±S.E.M. Statistical analysis
on real-time PCR was performed on raw ΔCt data (n= 4 animals per group).
XBP1 splice assay. Complementary DNA was synthesized and real-time PCR
reactions were performed by using the Fast SYBR Green Master Mix (Applied
Biosystems) according to the manufacturer’s protocol on a 7500 fast real-time PCR
system (Applied Biosystems). Primers for spliced XBP1 (5′-CTGAGTCCGAA
TCAGGTGCAG-3′ and 5′-ATCCATGGGGAGATGTTC-3′), unspliced XBP1 (5′-CAC
ACTCAGACTACGTGCA-3′ and 5′-ATCCATGGGGAGATGTTCTGG-3′) and total
XBP1 (5′-TGGCCGGGTCTGCTGAGTCCG-3′ and 5′-ATCCATGGGGAGATGTTCT
GG-3′) were designed according to Oslowski et al.43
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